Edaravone for amyotrophic lateral sclerosis: More evidence for long-term benefit
Muscle Nerve
.
2020 Feb;61(2):129-130.
doi: 10.1002/mus.26770.
Epub 2019 Dec 13.
Authors
B Jane Distad
1
,
Michael D Weiss
1
Affiliation
1
Division of Neuromuscular Diseases, Department of Neurology, University of Washington, Seattle, Washington, DC.
PMID:
31778230
DOI:
10.1002/mus.26770
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Amyotrophic Lateral Sclerosis*
Edaravone
Humans
Neuroprotective Agents*
Substances
Neuroprotective Agents
Edaravone